Skip to content

Clinical trials

Phase 1 Schizophrenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 1 Clear all

335 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20039
200412
200510
200613
200719
200817
200925
201013
201118
201217
201322
201420
201514
201611
20179
201813
20199
202010
202117
202214
20239
202412
202510
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed272
Terminated20
Unknown status16
Recruiting11
Withdrawn7
Not yet recruiting5
Active, not recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.31
Otsuka Pharmaceutical Development & Commercialization, Inc.28
GlaxoSmithKline15
Wyeth is now a wholly owned subsidiary of Pfizer11
Yale University11
Luye Pharma Group Ltd.9
Pfizer8
Merck Sharp & Dohme LLC7
Sumitomo Pharma America, Inc.6
Biogen5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia335
Psychotic Disorders68
Mood Disorders23
Bipolar Disorder15
Mental Disorders11
Cognitive Dysfunction6
Schizophrenia Spectrum and Other Psychotic Disorders6
Cognition Disorders5
Alzheimer Disease4
Major Depressive Disorder4

Trials

Showing 51 to 75 of 335. Each trial links to its page on Pharma Observatory.

235 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.